Global Diabetes Care Devices Market Size, Share, Growth Analysis Report - Forecast 2034

Diabetes Care Devices Market

Diabetes Care Devices Market By Glucose Monitoring Device (Blood Glucose Meters, Blood Glucose Test Strips, Lancing Devices, Continuous Glucose Monitoring Devices, HbA1c Testing Kits, And Others), By Insulin Delivery Device (Insulin Pumps, Insulin Syringes, And Insulin Pens), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034

Category: Medical Device Report Format : PDF Pages: 150 Report Code: ZMR-192 Published Date: Apr-2025 Status : Published
Market Size in 2024 Market Forecast in 2034 CAGR (in %) Base Year
USD 32.92 Billion USD 75.11 Billion 8.6% 2024

Diabetes Care Devices Market Size

The global diabetes care devices market size was worth around USD 32.92 Billion in 2024 and is predicted to grow to around USD 75.11 Billion by 2034 with a compound annual growth rate (CAGR) of roughly 8.6% between 2025 and 2034.

The report analyzes the global diabetes care devices market's drivers, restraints/challenges, and the effect they have on the demands during the projection period. In addition, the report explores emerging opportunities in the diabetes care devices industry.

Global Diabetes Care Devices Market SizeRequest Free Sample

Diabetes Care Devices Market: Overview

Diabetes care equipment is utilized for monitoring glucose levels of diabetics. Furthermore, these instruments enable insulin delivery into body of patient. In addition to this, diabetes is a chronic condition in which pancreas fails to produce enough amount of insulin for regulating sugar in human system. For the record, diabetes was tenth biggest mortality cause in 2019 as it was responsible for nearly 2 million deaths. Such incidences have prompted demand for diabetes care devices across globe.

The increasing demand for diabetes devices is attributed to preventing longer hospital stays and higher mortality rates in diabetic patients. As these devices facilitate continuous monitoring and management of blood sugar levels, they empower patients to proactively address their condition, thereby potentially avoiding severe complications that could necessitate extended hospitalization. Moreover, by enabling timely adjustments to treatment regimens, these devices contribute to better disease management and outcomes, ultimately leading to improved quality of life for individuals with diabetes. As a result, the increasing use of diabetes devices highlights their vital importance in improving patient care and well-being.

The market is growing due to the increasing prevalence of diabetes resulting from aging, obesity, and unhealthy lifestyle choices. Obesity is a significant factor leading to diabetes. According to the National Center for Biotechnology Information (NCBI) in October 2023, if the current trends continue, by 2035, more than half of the world's population will be overweight or obese, and the majority of new diabetes cases will be type 2 diabetes, driven by shifts in obesity rates and dietary risks. Factors such as overweight and obesity are contributing to a rise in diabetes cases. Consequently, risk factors like smoking, being overweight or obese, and having high cholesterol levels are anticipated to elevate the prevalence of diabetes, thereby increasing the demand for diabetes devices.

Key Insights

  • As per the analysis shared by our research analyst, the global diabetes care devices market is estimated to grow annually at a CAGR of around 8.6% over the forecast period (2025-2034).
  • Regarding revenue, the global diabetes care devices market size was valued at around USD 32.92 Billion in 2024 and is projected to reach USD 75.11 Billion by 2034.
  • The diabetes care devices market is projected to grow at a significant rate due to increasing prevalence of diabetes, rising adoption of continuous glucose monitoring and insulin delivery systems, growing demand for minimally invasive technologies, and advancements in digital health and smart diabetes management solutions.
  • Based on Glucose Monitoring Device, the Blood Glucose Meters segment is expected to lead the global market.
  • On the basis of Insulin Delivery Device, the Insulin Pumps segment is growing at a high rate and will continue to dominate the global market.
  • Based on region, North America is predicted to dominate the global market during the forecast period.

Global Diabetes Care Devices MarketRequest Free Sample

Diabetes Care Devices Market: Growth Drivers

Rise in cases of diabetics owing to inactive lifestyle along with swift industrialization will steer diabetes care devices market size. Furthermore, use of advanced blood glucose monitoring tools along with minimally invasive insulin delivery equipment for detecting diabetes has resulted in humungous demand for diabetes care devices in healthcare sector. Moreover, obesity issues and prominent surge in number of diabetes patients will fuel expansion of diabetes care devices market.

Furthermore, diabetes is assessed to be related to nearly 11.2% of global deaths across globe in coming years. Rising awareness pertaining to treatment of diabetes and supportive national health plans are set to expedite expansion of diabetes care devices industry. Moreover, diabetes is occurring at higher frequency in youth owing to irregular working hours and food habits. These, in turn, have created massive need of diabetes care devices in healthcare sector, thereby driving market progress.

Diabetes Care Devices Market: Segmentation Analysis

The global diabetes care devices market is segmented based on Glucose Monitoring Device, Insulin Delivery Device, and region.

Based on Glucose Monitoring Device, the global diabetes care devices market is divided into Blood Glucose Meters, Blood Glucose Test Strips, Lancing Devices, Continuous Glucose Monitoring Devices, HbA1c Testing Kits, And Others.

On the basis of Insulin Delivery Device, the global diabetes care devices market is bifurcated into Insulin Pumps, Insulin Syringes, And Insulin Pens.

Diabetes Care Devices Market: Report Scope

Report Attributes Report Details
Report Name Diabetes Care Devices Market
Market Size in 2024 USD 32.92 Billion
Market Forecast in 2034 USD 75.11 Billion
Growth Rate CAGR of 8.6%
Number of Pages 150
Key Companies Covered Terumo Corporation, Acon Laboratories Inc., Abbott Laboratories, Dexcom Inc., Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Merck & Co. Inc., The Ypsomed Group, Roche Diagnostics Ltd., Becton, Dickinson and Company, Medtronic plc, ARKRAY Inc., Sanofi S.A.,, and others.
Segments Covered By Glucose Monitoring Device, By Insulin Delivery Device, and By Region
Regions Covered North America, Europe, Asia Pacific (APAC), Latin America, The Middle East and Africa (MEA)
Base Year 2024
Historical Year 2020 to 2023
Forecast Year 2025 - 2034
Customization Scope Avail customized purchase options to meet your exact research needs. Request For Customization

Diabetes Care Devices Market: Regional Analysis

North American Diabetes Care Devices Market To Record Astounding Growth By 2034

Growth of diabetes care devices market in North America over forecasting timeline is subject to rise in number of diabetics in North America. For the record, recently there are over 30 million diabetics in North America and the number is projected to surge to about 34 million in 2026. Furthermore, supportive reimbursement guidelines along with strong presence of healthcare infrastructure in countries such as the U.S. and Canada will proliferate regional market surge.

Diabetes Care Devices Market: Competitive Analysis

The report provides a company market share analysis to give a broader overview of the key market players. In addition, the report also covers key strategic developments of the market, including acquisitions & mergers, new product launches, agreements, partnerships, collaborations & joint ventures, research & development, and regional expansion of major participants involved in the diabetes care devices market on a global and regional basis.

The global diabetes care devices market is dominated by players like:

  • Terumo Corporation
  • Acon Laboratories Inc.
  • Abbott Laboratories
  • Dexcom Inc.
  • Novo Nordisk A/S
  • Johnson & Johnson
  • Bayer AG
  • Merck & Co. Inc.
  • The Ypsomed Group
  • Roche Diagnostics Ltd.
  • Becton
  • Dickinson and Company
  • Medtronic plc
  • ARKRAY Inc.
  • Sanofi S.A.

The global diabetes care devices market is segmented as follows;

By Glucose Monitoring Device

  • Blood Glucose Meters
  • Blood Glucose Test Strips
  • Lancing Devices
  • Continuous Glucose Monitoring Devices
  • HbA1c Testing Kits
  • And Others

By Insulin Delivery Device

  • Insulin Pumps
  • Insulin Syringes
  • And Insulin Pens

By Region

  • North America
    • The U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia Pacific
  • The Middle East & Africa
    • Saudi Arabia
    • UAE
    • Egypt
    • Kuwait
    • South Africa
    • Rest of the Middle East & Africa
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America

Table Of Content

Methodology

FrequentlyAsked Questions

The global diabetes care devices market is expected to grow due to rising prevalence of diabetes worldwide, coupled with technological advancements in monitoring and insulin delivery systems.
According to a study, the global diabetes care devices market size was worth around USD 32.92 Billion in 2024 and is expected to reach USD 75.11 Billion by 2034.
The global diabetes care devices market is expected to grow at a CAGR of 8.6% during the forecast period.
North America is expected to dominate the diabetes care devices market over the forecast period.

Leading players in the global diabetes care devices market include Terumo Corporation, Acon Laboratories Inc., Abbott Laboratories, Dexcom Inc., Novo Nordisk A/S, Johnson & Johnson, Bayer AG, Merck & Co. Inc., The Ypsomed Group, Roche Diagnostics Ltd., Becton, Dickinson and Company, Medtronic plc, ARKRAY Inc., Sanofi S.A.,, among others.

The report explores crucial aspects of the diabetes care devices market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.

Choose License Type

  • zion payment modes

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed